about
Antiplatelet agents for chronic kidney diseaseAntiplatelet agents for chronic kidney diseaseAntiplatelet agents for chronic kidney diseaseEndothelin and the glomerulus in chronic kidney diseasePharmacologic management of chronic reno-cardiac syndromeArterial stiffness, vascular calcification and bone metabolism in chronic kidney diseaseAssociation of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study.Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure.The longevity of arteriovenous graft for hemodialysis patients--externally supported or nonsupported.Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study.Contrast-induced nephropathy in patients undergoing percutaneous coronary interventionIron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.Association of response to hepatitis B vaccination and survival in dialysis patientsCan genetic pleiotropy replicate common clinical constellations of cardiovascular disease and risk?Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients.Soluble TWEAK independently predicts atherosclerosis in renal transplant patients.Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.A call to action: variability in guidelines for cardiac evaluation before renal transplantation.Endonuclease G mediates endothelial cell death induced by carbamylated LDL.Frequency of pulmonary hypertension in hemodialysis patients.Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKDFetuin-A, inflammation, and coronary artery calcification in hemodialysis patientsDarbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation.The Relationship between Serum Oxalic Acid, Central Hemodynamic Parameters and Colonization by Oxalobacter formigenes in Hemodialysis Patients.The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients.Reverse Remodeling and Prognosis Following Kidney Transplantation in Contemporary Patients With Cardiac DysfunctionRelationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.Angina pectoris and intensive intravenous iron treatment in hemodialysis patients.Protein carbamylation predicts mortality in ESRD.Ionizing radiation exposure among kidney transplant recipients due to medical imaging during the pretransplant evaluation.Experimentally-Induced Metabolic Acidosis Does not Alter Aortic Fatty Streak Formation in High-Cholesterol Fed Rabbits.Bioprosthetic versus mechanical prostheses for valve replacement in end-stage renal disease patients: systematic review and meta-analysis.Peri-aortic fat tissue thickness in peritoneal dialysis patients.High hemodialysis vascular access flow and impaired right ventricular function in chronic hemodialysis patients.Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients.Risk factors for mortality in hemodialysis patients: two-year follow-up study.Costs and effectiveness of cardiac rehabilitation for dialysis patients following coronary bypassChronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.Detection of microcirculatory impairment by transcutaneous oxymetry monitoring during hemodialysis: an observational study.
P2860
Q24197614-74839749-6504-4AD2-A5E0-BF42EB7DCE33Q24200752-AD943713-570E-4277-B00E-6BBC837CE4F7Q24234115-F65347C4-48D8-4DFB-A507-CE76089CAC1BQ26828634-6E436087-90C1-48D6-B3F9-22FFF61B55CAQ26829812-08A5C193-9D00-472B-AA67-44BA8D68D952Q27024623-13B63399-FE16-46A3-A72E-7BEB560C8B0AQ33407103-172A7237-A9B7-4DD8-AB2B-089E048071B3Q33511547-13A51B96-8332-4066-9A4A-E4BD3E393F46Q33888388-5253B065-41F1-46CA-9475-05743E4E6FCAQ34139955-321FB048-373F-4EEC-BEBB-493CEEF383CEQ34155673-ED1E169B-C48F-4930-B1CF-201DC2B4D25CQ34333986-AF6C76CA-FE8E-45D6-869A-8EC1FA49B18CQ34398430-D8E31EC1-DA88-4F43-80BC-3B8A7009C151Q34431231-E51040C1-0834-407B-8D22-013B5C718A4FQ34751797-AF64BBE3-403D-479C-BCE4-90DF50FA5E95Q34815993-C6CEEB6D-FA15-4B98-8533-C18BF0E4B8A7Q34911214-AAC80AE8-2872-42DB-BCD9-B057A1461CD6Q34927152-37A8ACE3-F5B8-4AC7-9472-01E7541ACE3DQ35056945-69BD3163-BC0D-400F-BC32-C9670D7D8217Q35060996-9FAB56CC-17A0-450F-95DA-CF6C25694900Q35064221-C363068A-2B09-43EC-BD5F-B70D8DAFBC7EQ35093885-6B53D4A8-6CD7-47FF-9393-F4ADCAA03587Q35106161-893CFEDD-F175-4742-8B23-A825C07F0BF4Q35700844-837DE632-5D98-481F-9319-6573631DCDCAQ35773125-A626A7AB-0EB5-4898-A812-4C94A1D62B05Q35985760-B84EE88B-46C8-45E0-96BA-4DD25FC042BEQ36191046-77E5D56E-3577-4D29-97F4-2D8CE1FC5ECCQ36551416-4DB7B34F-2B31-4B10-A96B-BF8830EBE3B2Q36765940-96AD26E6-EB52-4939-9E69-A4D4FAA42F8FQ36796565-06C58B2C-46B6-4B66-89B7-021C572395BAQ36810455-5B85DAC9-8349-4AF3-BE3E-395ED18CC432Q36821902-296F56D2-34A4-4C16-9B5F-49E1CA6DD4ACQ36829784-03ED8CBD-1C83-4064-AC22-FBF7034384E0Q36831518-744959ED-CFF2-4CEA-ADEF-CAAA6025DEBAQ37241097-8EF88488-E424-473B-9DFF-37EEA58E9FB2Q37360393-9372EE7D-C3B5-4E06-87FB-42D6AC7A6B86Q37379663-83C63BC0-D11F-44F7-B025-5287761BF2F4Q37421762-597415BC-5E49-4B8B-A966-521C5CD9F712Q37524926-5F80CA4C-8A00-4BB0-A8CB-6693BD38BC47Q37529494-2D86F660-98D2-4CBB-BADB-9AD161F06D86
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cardiovascular mortality in end-stage renal disease.
@ast
Cardiovascular mortality in end-stage renal disease.
@en
type
label
Cardiovascular mortality in end-stage renal disease.
@ast
Cardiovascular mortality in end-stage renal disease.
@en
prefLabel
Cardiovascular mortality in end-stage renal disease.
@ast
Cardiovascular mortality in end-stage renal disease.
@en
P1476
Cardiovascular mortality in end-stage renal disease.
@en
P2093
Allan J Collins
P304
P356
10.1097/00000441-200304000-00002
P407
P577
2003-04-01T00:00:00Z